BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 36199201)

  • 1. A pharmacometrics approach to assess the feasibility of capillary microsampling to replace venous sampling in clinical studies: Tafenoquine case study.
    Bachhav SS; Taylor M; Martin A; Green JA; Duparc S; Rolfe K; Sharma H; Tan LK; Goyal N
    Br J Clin Pharmacol; 2023 Mar; 89(3):1187-1197. PubMed ID: 36199201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial.
    Thakkar N; Green JA; Koh GCKW; Duparc S; Tenero D; Goyal N
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial.
    Vélez ID; Hien TT; Green JA; Martin A; Sharma H; Rousell VM; Breton JJ; Ernest TB; Rolfe K; Taylor M; Mohamed K; Jones SW; Chau NH; Hoa NT; Duparc S; Tan LK; Goyal N
    Lancet Child Adolesc Health; 2022 Feb; 6(2):86-95. PubMed ID: 34871570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of the Stable Isotope Label Approach in Clinical Development-Supporting Dissolution Specifications for a Commercial Tablet Product with Tafenoquine, a Long Half-life Compound.
    Goyal N; Mohamed K; Rolfe K; Sahota S; Ernest T; Duparc S; Taylor M; Casillas L; Koh GCKW
    AAPS J; 2018 Jun; 20(4):74. PubMed ID: 29869298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
    Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetics of tafenoquine during malaria prophylaxis in healthy subjects.
    Charles BG; Miller AK; Nasveld PE; Reid MG; Harris IE; Edstein MD
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2709-15. PubMed ID: 17517850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of the new antimalarial agent tafenoquine in Thai soldiers.
    Edstein MD; Kocisko DA; Brewer TG; Walsh DS; Eamsila C; Charles BG
    Br J Clin Pharmacol; 2001 Dec; 52(6):663-70. PubMed ID: 11736877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pharmacokinetic study of radiprodil oral suspension in healthy adults comparing conventional venous blood sampling with two microsampling techniques.
    Sciberras D; Otoul C; Lurquin F; Smeraglia J; Lappert A; De Bruyn S; Jaap van Lier J
    Pharmacol Res Perspect; 2019 Feb; 7(1):e00459. PubMed ID: 30705758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tacrolimus Area Under the Concentration Versus Time Curve Monitoring, Using Home-Based Volumetric Absorptive Capillary Microsampling.
    Gustavsen MT; Midtvedt K; Vethe NT; Robertsen I; Bergan S; Åsberg A
    Ther Drug Monit; 2020 Jun; 42(3):407-414. PubMed ID: 31479042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential cytochrome P450 2D metabolism alters tafenoquine pharmacokinetics.
    Vuong C; Xie LH; Potter BM; Zhang J; Zhang P; Duan D; Nolan CK; Sciotti RJ; Zottig VE; Nanayakkara NP; Tekwani BL; Walker LA; Smith PL; Paris RM; Read LT; Li Q; Pybus BS; Sousa JC; Reichard GA; Smith B; Marcsisin SR
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3864-9. PubMed ID: 25870069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects.
    Miller AK; Harrell E; Ye L; Baptiste-Brown S; Kleim JP; Ohrt C; Duparc S; Möhrle JJ; Webster A; Stinnett S; Hughes A; Griffith S; Beelen AP
    Br J Clin Pharmacol; 2013 Dec; 76(6):858-67. PubMed ID: 23701202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of capillary microsampling for rat pharmacokinetic studies: Comparison of tail-vein bleed to jugular vein cannula sampling.
    Korfmacher W; Luo Y; Ho S; Sun W; Shen L; Wang J; Wu Z; Guo Y; Snow G; O'Shea T
    J Pharmacol Toxicol Methods; 2015; 76():7-14. PubMed ID: 26164093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microsampling to support pharmacokinetic clinical studies in pediatrics.
    Guerra Valero Y; Dorofaeff T; Parker L; Coulthard MG; Sparkes L; Lipman J; Wallis SC; Roberts JA; Parker SL
    Pediatr Res; 2022 May; 91(6):1557-1561. PubMed ID: 34023854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rajapakse S; Rodrigo C; Fernando SD
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010458. PubMed ID: 25921416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tafenoquine: First Global Approval.
    Frampton JE
    Drugs; 2018 Sep; 78(14):1517-1523. PubMed ID: 30229442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tafenoquine for preventing relapse in people with Plasmodium vivax malaria.
    Rodrigo C; Rajapakse S; Fernando D
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD010458. PubMed ID: 32892362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.
    Wilhelm AJ; de Graaf P; Veldkamp AI; Janssen JJ; Huijgens PC; Swart EL
    Br J Clin Pharmacol; 2012 Apr; 73(4):553-63. PubMed ID: 21988410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population pharmacokinetics and Bayesian estimation of tacrolimus exposure in paediatric liver transplant recipients.
    Kassir N; Labbé L; Delaloye JR; Mouksassi MS; Lapeyraque AL; Alvarez F; Lallier M; Beaunoyer M; Théorêt Y; Litalien C
    Br J Clin Pharmacol; 2014 Jun; 77(6):1051-63. PubMed ID: 24977292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tafenoquine: a promising new antimalarial agent.
    Crockett M; Kain KC
    Expert Opin Investig Drugs; 2007 May; 16(5):705-15. PubMed ID: 17461742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.